The next-generation CGM is now available in Sweden, with launches expected in Germany, Spain and Italy during the coming weeks as part of a ...

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous ...

Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the design, development and commercialization of glucose monitoring products designed to transform lives in the global ...

Q1 2026 Management view "2026 is off to a very strong start for Senseonics commercially and strategically" (President, CEO & Director Tim Goodnow), who said the company delivered "$11.7 million in ...

Any statements in this press release about the Company’s planned transfer to the Nasdaq Global Select Market and the expected timing thereof, and other statements containing the words "believe," ...

Senseonics and newcomer pump developer Sequel Med Tech have a plan to connect their diabetes technologies, with the goal of delivering what they describe as the first automated insulin delivery system ...

Detailed price information for Senseonics Holdings Inc (SENS-Q) from The Globe and Mail including charting and trades.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) raised its full-year 2026 revenue outlook after reporting first-quarter ...

(RTTNews) - Senseonics Holdings, Inc. (SENS), a commercial-stage medical technology company, reported fourth-quarter and full-year results with revenue growth. The company expects full year 2026 ...

GERMANTOWN, Md., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (SENS), a medical technology company focused on the development, manufacturing and commercialization of long-term, ...

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous ...